Philstar Life has a roundup of where Eli Lilly's experimental retatrutide stands in 2026. Specifics were not available here, so tap through for the details.
Recap by typeshit. Full story at Philstar Life.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
Polskie Radio covers the next wave of weight loss drugs, with retatrutide and CagriSema named. Few details were available beyond the topic itself.
10:44
A personal account of a month on retatrutide, a drug still in trials and not approved for sale. It amounts to one person's anecdote, with no sourcing given.
Loading…